Bank Hapoalim BM grew its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 262.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,539 shares of the semiconductor company’s stock after acquiring an additional 1,114 shares during the quarter. Bank Hapoalim BM’s holdings in Synopsys were worth $759,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Maryland State Retirement & Pension System raised its holdings in shares of Synopsys by 22.6% in the third quarter. Maryland State Retirement & Pension System now owns 9,194 shares of the semiconductor company’s stock valued at $4,536,000 after buying an additional 1,693 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in Synopsys by 19.2% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 10,628 shares of the semiconductor company’s stock worth $5,244,000 after buying an additional 1,713 shares during the last quarter. Evergreen Capital Management LLC lifted its stake in shares of Synopsys by 68.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 2,651 shares of the semiconductor company’s stock worth $1,308,000 after acquiring an additional 1,076 shares during the period. NBT Bank N A NY lifted its stake in shares of Synopsys by 13.4% in the 3rd quarter. NBT Bank N A NY now owns 279 shares of the semiconductor company’s stock worth $138,000 after acquiring an additional 33 shares during the period. Finally, ASR Vermogensbeheer N.V. boosted its holdings in shares of Synopsys by 12.0% in the third quarter. ASR Vermogensbeheer N.V. now owns 22,621 shares of the semiconductor company’s stock valued at $11,161,000 after acquiring an additional 2,419 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Stock Up 1.6%
Shares of SNPS stock opened at $516.31 on Friday. The business’s fifty day moving average is $455.35 and its 200-day moving average is $504.95. The stock has a market cap of $98.78 billion, a PE ratio of 64.62, a price-to-earnings-growth ratio of 4.30 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Analysts Set New Price Targets
A number of research firms recently weighed in on SNPS. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and decreased their price target for the company from $605.00 to $560.00 in a research note on Tuesday, December 9th. Needham & Company LLC raised their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. JPMorgan Chase & Co. boosted their target price on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Morgan Stanley lifted their price target on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Finally, Wells Fargo & Company upped their price target on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $553.57.
Check Out Our Latest Stock Analysis on SNPS
Insiders Place Their Bets
In related news, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,157 shares of company stock valued at $1,945,036 over the last quarter. 0.62% of the stock is currently owned by corporate insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- Wall Street Alert: Buy AES
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
